🔗 Share this article

The top legal official in Texas Paxton is taking legal action against the producers of Tylenol, alleging the corporations hid alleged dangers that the medication created to children's cognitive development.

This legal action arrives four weeks after Donald Trump publicized an unsubstantiated connection between taking Tylenol - also known as acetaminophen - throughout gestation and autism spectrum disorder in young ones.

The attorney general is suing the pharmaceutical giant, which once produced the medication, the sole analgesic suggested for pregnant women, and the current manufacturer, which presently makes it.

In a declaration, he said they "betrayed America by profiting off of discomfort and promoting medication ignoring the potential hazards."

The manufacturer says there is no credible evidence linking Tylenol to autism spectrum disorder.

"These companies lied for decades, intentionally threatening numerous people to increase profits," Paxton, from the Republican party, said.

The company commented that it was "deeply concerned by the spread of false claims on the security of acetaminophen and the potential impact that could have on the welfare of American women and children."

On its website, the company also said it had "continuously evaluated the pertinent research and there is lacking reliable evidence that demonstrates a verified association between using paracetamol and autism."

Associations acting on behalf of medical professionals and healthcare providers concur.

The leading OB-GYN organization has declared acetaminophen - the main ingredient in Tylenol - is one of the few options for expectant mothers to manage discomfort and fever, which can present significant medical dangers if left untreated.

"In multiple decades of research on the consumption of acetaminophen in pregnancy, zero credible investigations has definitively established that the use of paracetamol in any stage of pregnancy results in neurological conditions in children," the association commented.

This legal action references latest statements from the former administration in asserting the drug is potentially dangerous.

In recent weeks, Trump raised alarms from health experts when he told women during pregnancy to "resist strongly" not to take acetaminophen when ill.

The US Food and Drug Administration then published an announcement that doctors should contemplate reducing the usage of acetaminophen, while also mentioning that "a direct connection" between the drug and autism spectrum disorder in young ones has not been proven.

The Health Department head Robert F Kennedy Jr, who supervises the Food and Drug Administration, had promised in spring to undertake "a massive testing and research effort" that would identify the cause of autism spectrum disorder in a limited time.

But authorities warned that identifying a unique factor of autism spectrum disorder - considered by experts to be the outcome of a complex mix of genetic and external influences - would prove challenging.

Autism spectrum disorder is a form of lifelong neurodivergence and impairment that affects how persons perceive and relate to the surroundings, and is identified using medical professional evaluations.

In his legal document, Paxton - who supports Trump who is seeking US Senate - alleges the manufacturer and Johnson & Johnson "deliberately disregarded and attempted to silence the evidence" around acetaminophen and autism spectrum disorder.

The case seeks to make the firms "remove any marketing or advertising" that states acetaminophen is secure for expectant mothers.

The court case mirrors the concerns of a group of mothers and fathers of young ones with autism spectrum disorder and attention deficit hyperactivity disorder who sued the producers of acetaminophen in recently.

The court dismissed the legal action, declaring studies from the plaintiffs' authorities was lacking definitive proof.